Discontinued — last reported Q4 '23
Humana 2031 increased by 37.5% to $11.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 60.7%, from $28.00M to $11.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
Helps investors model the long-term earnings impact of intangible asset depreciation.
The projected amortization expense for finite-lived intangible assets specifically for the fiscal year 2031. It represen...
Standard multi-year amortization schedule disclosure.
other_finite_lived_intangible_assets_amortization_expens_5777a7| Q1 '23 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $27.00M | $29.00M | $27.00M | $27.00M | $27.00M | $28.00M | $28.00M | $8.00M | $11.00M |
| QoQ Change | — | +7.4% | -6.9% | +0.0% | +0.0% | +3.7% | +0.0% | -71.4% | +37.5% |
| YoY Change | — | — | +0.0% | -6.9% | — | +3.7% | +3.7% | -70.4% | -60.7% |